DYNLT2B

gene
On this page

Also known as MGC33212

Summary

DYNLT2B (dynein light chain Tctex-type 2B, HGNC:28482) is a protein-coding gene on chromosome 3q29, encoding Dynein light chain Tctex-type protein 2B (Q8WW35). Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 2 complex (dynein-2 complex), a motor protein complex that drives the movement of cargos along microtubules within cilia and flagella in concert with the intraflagellar transport (IFT) system.

Dyneins are a group of microtubule-activated ATPases that function as molecular motors. They are divided into two subgroups of axonemal and cytoplasmic dyneins. The cytoplasmic dyneins function in intracellular motility, including retrograde axonal transport, protein sorting, organelle movement, and spindle dynamics. Molecules of conventional cytoplasmic dynein are comprised of 2 heavy chain polypeptides and a number of intermediate and light chains. This gene encodes a subunit of the human cytoplasmic dynein-2 complex. Mutations in this gene are associated with short-rib thoracic dysplasia 17 with or without polydactyly. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Source: NCBI Gene 255758 — RefSeq curated summary.

At a glance

  • Gene–disease (curated): short-rib thoracic dysplasia 17 with or without polydactyly (Strong, GenCC)
  • Clinical variants (ClinVar): 90 total — 9 pathogenic, 1 likely-pathogenic
  • Phenotypes (HPO): 13
  • MANE Select transcript: NM_152773

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28482
Approved symbolDYNLT2B
Namedynein light chain Tctex-type 2B
Location3q29
Locus typegene with protein product
StatusApproved
AliasesMGC33212
Ensembl geneENSG00000213123
Ensembl biotypeprotein_coding
OMIM617353
Entrez255758

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 5 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000325318, ENST00000426563, ENST00000446494, ENST00000465757, ENST00000491186, ENST00000931282, ENST00000931283, ENST00000931284, ENST00000943620

RefSeq mRNA: 2 — MANE Select: NM_152773 NM_001351628, NM_152773

CCDS: CCDS33929

Canonical transcript exons

ENST00000325318 — 5 exons

ExonStartEnd
ENSE00001506975196318040196318240
ENSE00003484696196296006196296069
ENSE00003648804196291219196291374
ENSE00003709844196306943196307012
ENSE00003709845196316098196316231

Expression profiles

Bgee: expression breadth ubiquitous, 135 present calls, max score 97.96.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.5024 / max 351.3502, expressed in 1716 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
4633914.95761689
463404.04741500
463411.4973933

Top tissues by expression

137 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right uterine tubeUBERON:000130297.96gold quality
cortical plateUBERON:000534395.97gold quality
olfactory segment of nasal mucosaUBERON:000538695.60gold quality
nucleus accumbensUBERON:000188294.93gold quality
hypothalamusUBERON:000189894.09gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099193.97gold quality
Brodmann (1909) area 9UBERON:001354093.87gold quality
right testisUBERON:000453493.63gold quality
caudate nucleusUBERON:000187393.52gold quality
left testisUBERON:000453393.45gold quality
dorsolateral prefrontal cortexUBERON:000983493.45gold quality
ganglionic eminenceUBERON:000402393.43gold quality
anterior cingulate cortexUBERON:000983593.23gold quality
amygdalaUBERON:000187693.22gold quality
temporal lobeUBERON:000187193.17gold quality
testisUBERON:000047392.92gold quality
putamenUBERON:000187492.76gold quality
right frontal lobeUBERON:000281092.70gold quality
ventricular zoneUBERON:000305392.53gold quality
cerebral cortexUBERON:000095692.43gold quality
brainUBERON:000095592.31gold quality
Ammon’s hornUBERON:000195492.25gold quality
primary visual cortexUBERON:000243691.80gold quality
superior frontal gyrusUBERON:000266191.61gold quality
frontal cortexUBERON:000187091.56gold quality
cerebellar hemisphereUBERON:000224591.43gold quality
cerebellar cortexUBERON:000212991.32gold quality
pituitary glandUBERON:000000791.23gold quality
cerebellumUBERON:000203791.17gold quality
right hemisphere of cerebellumUBERON:001489091.06gold quality

Single-cell (SCXA)

Detected in 6 experiment(s), a significant marker in 5.

ExperimentMarker?Max mean expression
E-CURD-114yes61.28
E-HCAD-1yes27.45
E-MTAB-10287yes27.02
E-ANND-3yes9.66
E-MTAB-9388yes7.12
E-MTAB-7606no416.29

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

11 targeting DYNLT2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-1213699.9872.815713
HSA-MIR-338-5P99.9272.342951
HSA-MIR-6875-3P99.8270.262983
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-16-2-3P99.2970.601954
HSA-MIR-195-3P99.2970.611954
HSA-MIR-520E-5P99.2768.901513
HSA-MIR-3145-3P98.8569.072031
HSA-MIR-6755-3P98.6166.90834
HSA-MIR-5000-5P97.4066.111055

Literature-anchored findings (GeneRIF, showing 3)

  • Tctex1d2 is a novel dynein light chain important for trafficking to the cilium and potentially retrograde intraflagellar transport. (PMID:25830415)
  • integral component of the evolutionarily conserved retrograde intraflagellar transport machinery (PMID:26044572)
  • WDR60 plays a major role and TCTEX1D2 plays an auxiliary role in the dynein-2 complex to mediate retrograde ciliary protein trafficking. (PMID:29742051)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriodynlt2bENSDARG00000054255
mus_musculusDynlt2bENSMUSG00000014075
rattus_norvegicusDynlt2b-ps1ENSRNOG00000000630
rattus_norvegicusDynlt2bENSRNOG00000001758
drosophila_melanogasterCG14763FBGN0033243
caenorhabditis_elegansWBGENE00017014

Paralogs (5): DYNLT1 (ENSG00000146425), DYNLT5 (ENSG00000152760), DYNLT3 (ENSG00000165169), DYNLT2 (ENSG00000184786), DYNLT4 (ENSG00000188396)

Protein

Protein identifiers

Dynein light chain Tctex-type protein 2BQ8WW35 (reviewed: Q8WW35)

Alternative names: Tctex1 domain-containing protein 2

All UniProt accessions (3): E7ER86, F8WD40, Q8WW35

UniProt curated annotations — full annotation on UniProt →

Function. Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 2 complex (dynein-2 complex), a motor protein complex that drives the movement of cargos along microtubules within cilia and flagella in concert with the intraflagellar transport (IFT) system. Required for proper retrograde ciliary transport.

Subunit / interactions. Light chain of the cytoplasmic dynein complex 2, a multisubunit complex composed at least of eleven different proteins. The cytoplasmic dynein 2 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs). Among them, a heavy chain (DYNC2H1), two intermediate chains (DYNC2I2 and DYNC2I1), a light intermediate chain (DYNC2LI1), and a light chain (DYNLT2B) are unique to the dynein-2 complex, but a subset of the light chains are also shared by dynein-1 and dynein-2 complexes. Interacts with DYNC2I1. The dimer DYNLT2B-DYNLT1/DYNLT3 interacts with DYNC2I1; this interaction is crucial for retrograde trafficking of ciliary proteins.

Subcellular location. Dynein axonemal particle.

Disease relevance. Short-rib thoracic dysplasia 17 with or without polydactyly (SRTD17) [MIM:617405] A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a ’trident’ appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. The disease is caused by variants affecting the gene represented in this entry.

Similarity. Belongs to the dynein light chain Tctex-type family.

RefSeq proteins (2): NP_001338557, NP_689986* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR005334Tctex-1-likeFamily
IPR038586Tctex-1-like_sfHomologous_superfamily

Pfam: PF03645

UniProt features (13 total): strand 5, helix 4, chain 1, sequence variant 1, turn 1, sequence conflict 1

Structure

Experimental structures (PDB)

2 structures.

PDBMethodResolution (Å)
8RGIX-RAY DIFFRACTION2.02
8J07ELECTRON MICROSCOPY4.1

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8WW35-F186.890.72

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-5620924Intraflagellar transport

MSigDB gene sets: 195 (showing top): GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, DARWICHE_SKIN_TUMOR_PROMOTER_UP, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOBP_CILIUM_ORGANIZATION, GOBP_REGULATION_OF_CELLULAR_LOCALIZATION, GOCC_CENTROSOME, GOBP_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT, GOBP_ORGANELLE_ASSEMBLY, GOBP_REGULATION_OF_CILIUM_ASSEMBLY

GO Biological Process (5): microtubule-based movement (GO:0007018), intraciliary retrograde transport (GO:0035721), cilium assembly (GO:0060271), regulation of cilium assembly (GO:1902017), regulation of intraciliary retrograde transport (GO:1905799)

GO Molecular Function (2): dynein intermediate chain binding (GO:0045505), protein binding (GO:0005515)

GO Cellular Component (9): cytoplasm (GO:0005737), cytoplasmic dynein complex (GO:0005868), cilium (GO:0005929), dynein axonemal particle (GO:0120293), spindle pole (GO:0000922), centrosome (GO:0005813), axoneme (GO:0005930), interphase microtubule organizing center (GO:0031021), ciliary base (GO:0097546)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Assembly of the 9+0 primary cilium1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure4
microtubule organizing center2
microtubule-based process1
intraciliary transport1
axoneme assembly1
intraciliary transport involved in cilium assembly1
cilium organization1
protein localization to cilium1
organelle assembly1
trans-Golgi to periciliary membrane compartment transport1
plasma membrane bounded cell projection assembly1
ciliary transition zone assembly1
cilium assembly1
regulation of plasma membrane bounded cell projection assembly1
regulation of organelle assembly1
regulation of intracellular transport1
intraciliary retrograde transport1
regulation of microtubule-based movement1
protein binding1
binding1
intracellular anatomical structure1
dynein complex1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1
cytoplasm1
intracellular membraneless organelle1
spindle1
centriole1
cytoskeleton1
microtubule1
ciliary plasm1
cilium1
ciliary transition zone1
ciliary transition fiber1

Protein interactions and networks

STRING

713 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
DYNLT2BDYNC2I1Q8WVS4922
DYNLT2BDYNC2LI1Q8TCX1904
DYNLT2BDYNC2I2Q96EX3874
DYNLT2BDYNC2H1Q8NCM8866
DYNLT2BDYNLRB1Q9NP97737
DYNLT2BDYNLT3P51808709
DYNLT2BDYNLRB2Q8TF09703
DYNLT2BSMCO1Q147U7649
DYNLT2BWDR53Q7Z5U6643
DYNLT2BDYNLL2Q96FJ2642
DYNLT2BCEP120Q8N960623
DYNLT2BWDR19Q8NEZ3618
DYNLT2BDYNLT1P63172605
DYNLT2BIFT140Q96RY7604
DYNLT2BDYNLL1P63167587

IntAct

57 interactions, top by confidence:

ABTypeScore
DYNLT1DYNLT2Bpsi-mi:“MI:0915”(physical association)0.790
DYNLT2BDYNLT1psi-mi:“MI:0914”(association)0.790
DYNLL1BLTP3Bpsi-mi:“MI:0914”(association)0.730
DYNLT1DYNC1LI2psi-mi:“MI:0914”(association)0.640
DYNC2I2DYNLL1psi-mi:“MI:0914”(association)0.640
DYNLL2BLTP3Bpsi-mi:“MI:0914”(association)0.640
ACTN2DYNLT2Bpsi-mi:“MI:0915”(physical association)0.560
CDKN2DDYNLT2Bpsi-mi:“MI:0915”(physical association)0.560
DYNLT2BSNX2psi-mi:“MI:0914”(association)0.530
COMMD10VPS26Cpsi-mi:“MI:0914”(association)0.530
DEFB121COL6A2psi-mi:“MI:0914”(association)0.530
GTF2F2DYNLT2Bpsi-mi:“MI:0915”(physical association)0.520
DYNLRB2PAFAH1B1psi-mi:“MI:0914”(association)0.510
DYNLT2BTIPRLpsi-mi:“MI:0914”(association)0.510
DYNC2I1ZRANB2psi-mi:“MI:0914”(association)0.510
DYNLT2BCSNK2Bpsi-mi:“MI:0915”(physical association)0.370
PPP2CBDYNLT2Bpsi-mi:“MI:0915”(physical association)0.370
TK1DYNLT2Bpsi-mi:“MI:0915”(physical association)0.370
VWA2WDR47psi-mi:“MI:0914”(association)0.350
ABHD17ADYNLT2Bpsi-mi:“MI:0914”(association)0.350
DYNC2LI1DYNLT1psi-mi:“MI:0914”(association)0.350
LETM2GAPDHSpsi-mi:“MI:0914”(association)0.350
NDUFB3NDUFS4psi-mi:“MI:0914”(association)0.350

BioGRID (60): TCTEX1D2 (Affinity Capture-MS), TCTEX1D2 (Proximity Label-MS), TCTEX1D2 (Two-hybrid), WDR60 (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS), WDR34 (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS), ABHD17B (Affinity Capture-MS), CLMN (Affinity Capture-MS), ABTB2 (Affinity Capture-MS), SNX6 (Affinity Capture-MS), SNX2 (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS)

ESM2 similar proteins: A7T1N0, B2RR83, F1QMY1, F1S5L4, O13648, O42857, O75343, P08487, P10686, P11985, P19174, P22717, P56523, P97311, P97564, Q04861, Q09315, Q14566, Q14BI7, Q21557, Q28BS0, Q28CM3, Q29JI9, Q2KIZ8, Q32P71, Q39579, Q3MHU3, Q4V339, Q5FWY4, Q5JTY5, Q5R746, Q5RIA9, Q5ZI74, Q61586, Q62077, Q6DNF3, Q8IUF1, Q8IZS6, Q8NDG6, Q8VEH6

Diamond homologs: A2VDD2, Q32P71, Q3B8D7, Q4VYA0, Q54PG1, Q5JR98, Q66IC8, Q8CDY7, Q8N7M0, Q8WW35, Q9CQ66, Q9D5I4, F1QMY1, P11985, P51807, Q8IZS6, Q94524, P51808, P56387, P63171, P63172, Q5NVF5, Q6XXL8, Q8SPS9, Q9Z336

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 45 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Intraflagellar transport743.8×4e-08
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal518.2×4e-04
Resolution of Sister Chromatid Cohesion616.2×2e-04
RHO GTPases Activate Formins614.6×3e-04
EML4 and NUDC in mitotic spindle formation514.5×7e-04
Mitotic Prometaphase613.0×4e-04
Separation of Sister Chromatids59.5×5e-03

GO biological processes:

GO termPartnersFoldFDR
microtubule-based movement641.2×1e-06

Disease & clinical

Clinical variants and AI predictions

ClinVar

90 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic9
Likely pathogenic1
Uncertain significance40
Likely benign26
Benign9

Top pathogenic / likely-pathogenic (10)

Variant IDHGVSClassification
2192828NM_152773.5(DYNLT2B):c.104dup (p.Gln36fs)Pathogenic
266107NM_152773.5(DYNLT2B):c.317+4A>TPathogenic
3649518NM_152773.5(DYNLT2B):c.221C>G (p.Ser74Ter)Pathogenic
3660585NM_152773.5(DYNLT2B):c.193G>T (p.Glu65Ter)Pathogenic
394282GRCh37/hg19 3q29(chr3:195780280-196264407)x3Pathogenic
417792NM_152773.5(DYNLT2B):c.262C>T (p.Arg88Ter)Pathogenic
417793NM_152773.5(DYNLT2B):c.100delinsCT (p.Val34fs)Pathogenic
4729518NM_152773.5(DYNLT2B):c.263del (p.Arg88fs)Pathogenic
686054GRCh37/hg19 3q29(chr3:195701149-197348561)x3Pathogenic
813328GRCh37/hg19 3q29(chr3:196033814-196033883)Likely pathogenic

SpliceAI

1448 predictions. Top by Δscore:

VariantEffectΔscore
3:196306941:A:ACdonor_gain1.0000
3:196306942:C:CCdonor_gain1.0000
3:196306942:CAATA:Cdonor_gain1.0000
3:196307008:CATTT:Cacceptor_gain1.0000
3:196307010:TTT:Tacceptor_gain1.0000
3:196307013:C:CCacceptor_gain1.0000
3:196318028:T:TAdonor_gain1.0000
3:196318083:C:CAdonor_gain1.0000
3:196318084:C:Adonor_gain1.0000
3:196318099:AG:Adonor_gain1.0000
3:196296004:A:ACdonor_gain0.9900
3:196296005:C:CCdonor_gain0.9900
3:196296005:CATT:Cdonor_gain0.9900
3:196296068:TG:Tacceptor_gain0.9900
3:196296070:C:CCacceptor_gain0.9900
3:196307009:ATTT:Aacceptor_gain0.9900
3:196307011:TT:Tacceptor_gain0.9900
3:196307011:TTCT:Tacceptor_loss0.9900
3:196307012:TC:Tacceptor_loss0.9900
3:196307012:TCTA:Tacceptor_loss0.9900
3:196307013:C:CAacceptor_loss0.9900
3:196307014:T:Aacceptor_loss0.9900
3:196316084:A:ACdonor_gain0.9900
3:196317957:T:TAdonor_gain0.9900
3:196317987:C:Adonor_gain0.9900
3:196318095:T:TAdonor_gain0.9900
3:196318136:C:CAdonor_gain0.9900
3:196292488:T:Cacceptor_gain0.9800
3:196296065:CCATG:Cacceptor_gain0.9800
3:196296066:CATG:Cacceptor_gain0.9800

AlphaMissense

942 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:196291360:G:CC132W0.999
3:196291343:C:TG138D0.998
3:196291363:G:CF131L0.998
3:196291363:G:TF131L0.998
3:196291365:A:GF131L0.998
3:196296035:C:GD118H0.998
3:196296050:A:GW113R0.998
3:196296050:A:TW113R0.998
3:196291361:C:TC132Y0.997
3:196291362:A:GC132R0.997
3:196296034:T:AD118V0.997
3:196306967:C:TG98E0.997
3:196306990:T:AK90N0.997
3:196306990:T:GK90N0.997
3:196316190:A:GL52P0.996
3:196316214:A:TV44D0.996
3:196316229:A:GF39S0.996
3:196291345:A:CF137L0.995
3:196291345:A:TF137L0.995
3:196291347:A:GF137L0.995
3:196296033:G:CD118E0.995
3:196296033:G:TD118E0.995
3:196296034:T:GD118A0.995
3:196296035:C:AD118Y0.995
3:196296058:C:GR110P0.995
3:196306982:A:TV93E0.995
3:196291336:G:CF140L0.993
3:196291336:G:TF140L0.993
3:196291338:A:GF140L0.993
3:196291344:C:GG138R0.993

dbSNP variants (sampled 300 via entrez): RS1000234732 (3:196319988 T>A,C,G), RS1000287728 (3:196307555 G>A), RS1000357265 (3:196318351 CG>C), RS1000565021 (3:196315647 T>G), RS1000616376 (3:196311337 G>A), RS1000625414 (3:196319015 G>A,T), RS1000690092 (3:196320227 C>T), RS1001045147 (3:196301319 T>G), RS1001098664 (3:196294464 G>A), RS1001286698 (3:196301289 T>A), RS1001334379 (3:196307599 G>A), RS1001443065 (3:196301479 G>A), RS1001493510 (3:196307585 G>C), RS1001559931 (3:196313589 T>A,C), RS1001610840 (3:196313915 T>C)

Disease associations

OMIM: gene MIM:617353 | disease phenotypes: MIM:617405, MIM:613091

GenCC curated gene-disease

DiseaseClassificationInheritance
short-rib thoracic dysplasia 17 with or without polydactylyStrongAutosomal recessive

ClinGen Gene-Disease Validity (1)

Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.

DiseaseClassificationInheritance
short-rib thoracic dysplasia 17 with or without polydactylyLimitedAR

Mondo (2): short-rib thoracic dysplasia 17 with or without polydactyly (MONDO:0054565), asphyxiating thoracic dystrophy 3 (MONDO:0013127)

Orphanet (4): Jeune syndrome (Orphanet:474), Short rib-polydactyly syndrome, Majewski type (Orphanet:93269), Short rib-polydactyly syndrome, Saldino-Noonan type (Orphanet:93270), Short rib-polydactyly syndrome, Verma-Naumoff type (Orphanet:93271)

HPO phenotypes

13 total (13 of 13 shown, HPO-id order):

HPOTerm
HP:0000007Autosomal recessive inheritance
HP:0000773Short ribs
HP:0000774Narrow chest
HP:0000888Horizontal ribs
HP:0000895Lateral clavicle hook
HP:0001156Brachydactyly
HP:0001162Postaxial hand polydactyly
HP:0001522Death in infancy
HP:0001830Postaxial foot polydactyly
HP:0003577Congenital onset
HP:0004322Short stature
HP:0010454Acetabular spurs
HP:0034374Trident acetabulum

GWAS associations

0 associations (top):

MeSH disease descriptors (1)

DescriptorNameTree numbers
C537602Short rib-polydactyly syndrome, Verma-Naumoff type (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases methylation, increases expression4
Air Pollutantsdecreases expression, increases abundance, increases expression2
Smokedecreases expression, increases abundance, increases expression2
Cyclosporinedecreases expression2
aristolochic acid Iincreases expression1
Esketaminedecreases expression1
decabromobiphenyl etheraffects expression1
dimethylselenidedecreases expression, increases expression, increases oxidation1
sodium arsenitedecreases expression, increases abundance1
beta-methylcholineaffects expression1
monomethylarsonous aciddecreases expression1
abrinedecreases expression1
Resveratrolaffects cotreatment, increases expression1
Temozolomideincreases expression1
Arsenicdecreases expression, increases abundance1
Estradioldecreases expression1
Plant Extractsaffects cotreatment, increases expression1
Quercetinincreases expression1
Silicon Dioxidedecreases expression1
Thimerosalincreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoindecreases expression1
Valproic Aciddecreases expression1
Aflatoxin B1increases methylation1
Hydroxyl Radicaldecreases expression, increases expression, increases oxidation1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.